Company / Shareholders' Equity
Indivior Shareholders' Equity History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$98.0M
FY2025
5-year range
-$337.0M / -$15.0M
FY2022-FY2025
Trend
+70.9%
vs FY2024
Sector context
#198 of 213
Health Care
What the data says
Indivior reports negative total equity of -$98M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$98M in FY2025.
Improved from -$184M to -$98M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 213This company -$98.0M Sector average $2.5B
▼
-103.8% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity increased 70.9% year-over-year.
- Ranks #198 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$98.0M | +70.9% |
| FY2024 | -$337.0M | -83.2% |
| FY2023 | -$184.0M | -1126.7% |
| FY2022 | -$15.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026